
James H. Reamer
Examiner (ID: 14078)
| Most Active Art Unit | 1206 |
| Art Unit(s) | 1206, 1205, 1614, 2746, 3106, 2899 |
| Total Applications | 2884 |
| Issued Applications | 2358 |
| Pending Applications | 157 |
| Abandoned Applications | 369 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1142457
[patent_doc_number] => 06777444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-17
[patent_title] => 'Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives'
[patent_app_type] => B2
[patent_app_number] => 10/270313
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 41
[patent_no_of_words] => 13383
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270313
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270313 | Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives | Oct 14, 2002 | Issued |
Array
(
[id] => 6640069
[patent_doc_number] => 20030212083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => new
[patent_app_number] => 10/181379
[patent_app_country] => US
[patent_app_date] => 2002-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2356
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181379 | Pharmaceutical composition | Oct 3, 2002 | Issued |
Array
(
[id] => 6843662
[patent_doc_number] => 20030149009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration'
[patent_app_type] => new
[patent_app_number] => 10/263044
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3162
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20030149009.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263044 | Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration | Sep 30, 2002 | Issued |
Array
(
[id] => 6839220
[patent_doc_number] => 20030036560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Methods and compositions for treating and preventing mucositis'
[patent_app_type] => new
[patent_app_number] => 10/260093
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3730
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036560.pdf
[firstpage_image] =>[orig_patent_app_number] => 10260093
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/260093 | Methods and compositions for treating and preventing mucositis | Sep 26, 2002 | Issued |
Array
(
[id] => 6716448
[patent_doc_number] => 20030027796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Phosphono-carboxylate compounds for treating amyloidosis'
[patent_app_type] => new
[patent_app_number] => 10/226613
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9438
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226613 | Phosphono-carboxylate compounds for treating amyloidosis | Aug 22, 2002 | Abandoned |
Array
(
[id] => 6852098
[patent_doc_number] => 20030144301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase'
[patent_app_type] => new
[patent_app_number] => 10/226815
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20983
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226815 | Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase | Aug 22, 2002 | Issued |
Array
(
[id] => 6697320
[patent_doc_number] => 20030109514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Platinum derivative pharmaceutical formulations'
[patent_app_type] => new
[patent_app_number] => 10/225607
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4996
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225607 | Platinum derivative pharmaceutical formulations | Aug 21, 2002 | Issued |
Array
(
[id] => 6736136
[patent_doc_number] => 20030013771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Method for preventing and treating peripheral neuropathy by administering selegiline'
[patent_app_type] => new
[patent_app_number] => 10/225522
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225522 | Method for preventing and treating peripheral neuropathy by administering selegiline | Aug 20, 2002 | Issued |
Array
(
[id] => 1271152
[patent_doc_number] => 06653351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-25
[patent_title] => 'Adjuvant chemotherapy for anaplastic gliomas'
[patent_app_type] => B2
[patent_app_number] => 10/218097
[patent_app_country] => US
[patent_app_date] => 2002-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9368
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218097 | Adjuvant chemotherapy for anaplastic gliomas | Aug 12, 2002 | Issued |
Array
(
[id] => 1347780
[patent_doc_number] => 06583142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-24
[patent_title] => 'Polymorphic form of a tachykinin receptor antagonist'
[patent_app_type] => B2
[patent_app_number] => 10/219386
[patent_app_country] => US
[patent_app_date] => 2002-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19874
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/583/06583142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219386 | Polymorphic form of a tachykinin receptor antagonist | Aug 11, 2002 | Issued |
Array
(
[id] => 1370944
[patent_doc_number] => 06558711
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Composition and method for reducing the risk of carcinogenesis'
[patent_app_type] => B1
[patent_app_number] => 10/210303
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7984
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210303 | Composition and method for reducing the risk of carcinogenesis | Jul 31, 2002 | Issued |
Array
(
[id] => 6730652
[patent_doc_number] => 20030186842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Treatment of infectious disease using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/208729
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 45942
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10208729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/208729 | Treatment of inflammation-associated disorders using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors | Jul 28, 2002 | Issued |
Array
(
[id] => 1342427
[patent_doc_number] => 06586404
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Pharmaceutical preparations of glutathione and methods of administration thereof'
[patent_app_type] => B1
[patent_app_number] => 10/200852
[patent_app_country] => US
[patent_app_date] => 2002-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20076
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200852 | Pharmaceutical preparations of glutathione and methods of administration thereof | Jul 21, 2002 | Issued |
Array
(
[id] => 1241255
[patent_doc_number] => 06683078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-27
[patent_title] => 'Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/194897
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39959
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/683/06683078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194897 | Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors | Jul 11, 2002 | Issued |
Array
(
[id] => 1248445
[patent_doc_number] => 06673792
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Broad-spectrum anti-emetic compositions and associated methods'
[patent_app_type] => B1
[patent_app_number] => 10/194868
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673792.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194868 | Broad-spectrum anti-emetic compositions and associated methods | Jul 10, 2002 | Issued |
Array
(
[id] => 1418327
[patent_doc_number] => 06509370
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-21
[patent_title] => 'Paclitaxel formulation'
[patent_app_type] => B1
[patent_app_number] => 10/192199
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7513
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192199 | Paclitaxel formulation | Jul 8, 2002 | Issued |
Array
(
[id] => 1228893
[patent_doc_number] => 06696493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-24
[patent_title] => 'Treating chronic uremic patients undergoing periodic dialysis'
[patent_app_type] => B2
[patent_app_number] => 10/189451
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 3128
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189451 | Treating chronic uremic patients undergoing periodic dialysis | Jul 7, 2002 | Issued |
Array
(
[id] => 1256447
[patent_doc_number] => 06667321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-23
[patent_title] => 'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'
[patent_app_type] => B2
[patent_app_number] => 10/189659
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35073
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/667/06667321.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189659 | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same | Jul 2, 2002 | Issued |
Array
(
[id] => 6869419
[patent_doc_number] => 20030082108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents'
[patent_app_type] => new
[patent_app_number] => 10/186070
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7599
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10186070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/186070 | Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents | Jun 27, 2002 | Issued |
Array
(
[id] => 1328070
[patent_doc_number] => 06599913
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Treating allergic and inflammatory conditions'
[patent_app_type] => B1
[patent_app_number] => 10/177271
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6352
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177271 | Treating allergic and inflammatory conditions | Jun 20, 2002 | Issued |